Overall rank by patents
#621
Across all tracked assignees
USPTO PatentsView assignee record - 711 granted patents across 79 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).
The verdict
Carefusion holds 711 US patents across 79 technology areas, rank #621 of 50,000 tracked assignees.
Carefusion 303, Inc. has been granted 711 US utility patents between 2015 and 2025, placing Carefusion 303, Inc. at rank #621 across all assignees tracked by PlainPatent. This portfolio spans 79 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.1 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a US Corporation, Carefusion 303, Inc. is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Carefusion sits between T-mobile Innovations Llc (715 patents, rank #617) and CJ Cheiljedang Corporation (709 patents, rank #625) - the closest US assignees by grant volume. The composite Innovation Score of 68.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 481 grants, compared with 230 in the 2015–2019 window, a +109% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Carefusion 303, Inc.'s 17.1 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 79 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Carefusion 303, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
T-Mobile Innovations LLC
715 patents
FG Innovation Company Limited
714 patents
Masimo Corporation
714 patents
JOLED INC.
713 patents
EASTMAN KODAK COMPANY
711 patents
CAREFUSION 303, INC.
711 patents
Johnson Controls Tyco IP Holdings LLP
710 patents
VIAVI Solutions Inc.
710 patents
CJ CHEILJEDANG CORPORATION
709 patents
What this shows Carefusion holds 711 patents at rank #621, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #621 in granted patent volume.
Other assignees with the most granted patents in Carefusion's primary technology class.
Carefusion's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
69 Top 1% higher than 99% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 45 | 6.3% |
| 2016 | 46 | 6.5% |
| 2017 | 40 | 5.6% |
| 2018 | 42 | 5.9% |
| 2019 | 57 | 8.0% |
| 2020 | 52 | 7.3% |
| 2021 | 67 | 9.4% |
| 2022 | 86 | 12.1% |
| 2023 | 100 | 14.1% |
| 2024 | 99 | 13.9% |
| 2025 | 77 | 10.8% |
Top 15 of 79 technology areas
Overall rank by patents
#621
Across all tracked assignees
68.7 out of 100
How to use this portfolio
Carefusion's 711 grants land it in the top 1% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.